PMI’s Mission and Objectives

PMI is committed to achieving the highest standards of academic research and to training the clinicians and scientists of the future, encouraging them to bridge the gap in delivering translational research which will meaningfully impact upon the diagnosis and treatment of men with prostate diseases and their families.

The initial objective of the PMI charity is to provide financial stability for the Prostate Biology Group (PBG). This will enable PBG to continue its work on identifying novel biomarkers and unravelling the mechanisms of how prostate cancers spread and become resistant to current treatments. PBGs work will aid early diagnosis and treatment of prostate cancer.

Lessons learnt whilst developing a sustainable PMI research unit (PBG) on Prostate Cancer will be applied to develop research units on Benign Prostatic Hyperplasia (BPH) and Prostatitis - culminating into a research institute focused entirely on conducting basic and translational research on prostate diseases.

PMI’s long term objective is to create an international network of research centres - all committed to the same ideal.